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GONADOTROPIN-RELEASING HORMONE IMPROVES
CONCEPTION RATES OF REPEAT-BREEDERS WITH
PREVIOUS REPRODUCTIVE DISORDERS
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Summary
An experiment examinIng the benefit of treating repeat-breeders with 100
Ilg GnRH (Cystoreli n4!l) at the time of third or fourth insemination was conducted
in 513 dairy cows of which 93 (abnormal cows) had been diagnosed previously
(during the 60 to 90 days postpartum) as having reproductive disorders, including
retained placenta, uterine infections, prolonged anestrus, and cystic ovaries.
Treatment with GnRH improved conception in normal and abnormal repeat-breeding
cows by 13 percentage points or 42%.
Introduction
Three types of cows contribute greatly to long calving intervals in dairy
herds. These include: (1) cows that do not show estrus or are not observed in heat
until 2-3 months after freshening, (2) cows that are found nonpregnant at
pregnancy checks, and (3) repeat-breeding cows. Successful treatments for the first
two problems were addressed previously in our research at Kansas State University
(see pp 66-70, 1986 Dairy Day." KAES Rep. Prog. 506).
Use of GnRH (Cystorelin®) at the time of insemination has increased
conception rates of repeat-breeders in our previous work at KSU (see pp 26-27,
1984 Dairy Day, KAES Rep. Prog. 460). However, the mechanism of GnRH's action
in the cow is not well understood. Furtherm ore, the previous health status of cows
given GnRH at repeat breedings has not been documented to determine if it is less
healthy cows that respond to GnRH at insemination. The objective of our study
was to determine if GnRH would improve conception I'ates in cows with previous
reproductive disorders.
Procedures
From November 1985 to August 1986, cows (n=513) in one large commercial
dairy herd with (n=93) or without (n=420) previous reproductive disorders were
given 100 Ilg GnRH (i.m.) after insemination or were left untreated at third and
fourth services. Previous reproductive problems included retained placentae (26%
of abnormal cows or 4.7% of all cows), uterine infections (27% or 4.9%), cystic
ovaries (31% or 5.6%), and prolonged anestrus (16% or 2.9%). As cows were
diagnosed (during first 60 to 90 days after calving), various veterinary treatments
were employed to resolve the reproductive problem. Cows were not assigned
randomly to treatment, but were treated according to the discretion of the
herdsman or of any of three inseminators. Treatment was based on the knowledge
that GnRH might improve conception ['ates of repeat-breeders. f
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Results and Discussion
Our results are summarized in Table 1. Treatment with GnRH tended to
improve (P=.13) conception rates from 12 to 25% in cows previously diagnosed with
reproductive disorders (abnormal cows) and increased (P<.05) conception rates from
36 to 47% in normal cows. Overall, conception rates improved by 13 percentage
points or 42% when GnRH was administered at the time of AI. The effect of health
status on conception rates was dramatic but not surprising, since conception rates
in normal cows (40%) were higher (P<.OOl) than those in abnormal cows (15%).
Table 1. Conception rates (%) of repeat-breeders given GnRH with (abnormal)
or without (normal) prior reproductive disorders
Treatment Normal Abnormal Total
GnRH 68/145 (47) 6/24 (25) 74/169 (44)a
Untreated 100/275 (36) 8/69 (12) 108/344 (31)
Total 168/420 (40)b 14/93 (15) 182/513 (35)
aDifferent from untreated cows (P<.05).
bOifferent from abnormal health status cows (P<.OOOl).
These results provide further evidence that GnRH is an effective treatment
for repeat-breeding dairy cows. A summary and updAte of all work utilizing GnRH
for treatment of repeat-breeders is found in this publication (pp 70-71). Although
it is not yet clear how GnRH improves fertility, fUI'ther work is underway to
better understand the physiology of GnRH's action.
